TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity
about
Differential modulation of Beta-adrenergic receptor signaling by trace amine-associated receptor 1 agonistsElectrophysiological effects of trace amines on mesencephalic dopaminergic neuronsAnatomical and functional evidence for trace amines as unique modulators of locomotor function in the mammalian spinal cordTrace amine-associated receptor 1 is a stereoselective binding site for compounds in the amphetamine classTrace Amines and the Trace Amine-Associated Receptor 1: Pharmacology, Neurochemistry, and Clinical ImplicationsTAAR1 Modulates Cortical Glutamate NMDA Receptor Function.d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology.Trace amine-associated receptor 1: A promising target for the treatment of psychostimulant addictionRactopamine, a livestock feed additive, is a full agonist at trace amine-associated receptor 1Methamphetamine and HIV-1-induced neurotoxicity: role of trace amine associated receptor 1 cAMP signaling in astrocytesTrace amine-associated receptors: ligands, neural circuits, and behaviorsDopamine receptors - IUPHAR Review 13"TAARgeting Addiction"--The Alamo Bears Witness to Another Revolution: An Overview of the Plenary Symposium of the 2015 Behavior, Biology and Chemistry ConferencePharmacological characterization of designer cathinones in vitroHIV-1, methamphetamine and astrocytes at neuroinflammatory CrossroadsTorpor: The Rise and Fall of 3-Monoiodothyronamine from Brain to Gut-From Gut to Brain?Activation of the trace amine-associated receptor 1 prevents relapse to cocaine seekingEffects of the trace amine-associated receptor 1 agonist RO5263397 on abuse-related effects of cocaine in rats.Membrane permeability of trace amines: evidence for a regulated, activity-dependent, nonexocytotic, synaptic release.Pharmacological profile of novel psychoactive benzofurans.Incretin-like effects of small molecule trace amine-associated receptor 1 agonists.Discovery and Characterization of 2-Aminooxazolines as Highly Potent, Selective, and Orally Active TAAR1 AgonistsGenetic Polymorphisms Affect Mouse and Human Trace Amine-Associated Receptor 1 Function.Role of TAAR1 within the Subregions of the Mesocorticolimbic Dopaminergic System in Cocaine-Seeking Behavior.Interactions of HIV and drugs of abuse: the importance of glia, neural progenitors, and host genetic factors.Effects of the trace amine associated receptor 1 agonist RO5263397 on abuse-related behavioral indices of methamphetamine in ratsFunctional interaction between trace amine-associated receptor 1 and dopamine D2 receptorAugmentation of methamphetamine-induced behaviors in transgenic mice lacking the trace amine-associated receptor 1Non-classical amine recognition evolved in a large clade of olfactory receptors.Agonists for 13 trace amine-associated receptors provide insight into the molecular basis of odor selectivity.A Transcriptome-Led Exploration of Molecular Mechanisms Regulating Somatostatin-Producing D-Cells in the Gastric Epithelium.Trace Amine-Associated Receptor 1 Regulation of Methamphetamine Intake and Related Traits.Brain-specific overexpression of trace amine-associated receptor 1 alters monoaminergic neurotransmission and decreases sensitivity to amphetamineA decade of pharma discovery delivers new tools targeting trace amine-associated receptor 1Pharmacological effects of 3-iodothyronamine (T1AM) in mice include facilitation of memory acquisition and retention and reduction of pain threshold.Avenues for the development of therapeutics that target trace amine associated receptor 1 (TAAR1).Latest trends in drugs of abuse - HIV infection and neuroAIDS.Trace amine associated receptor 1 modulates behavioral effects of ethanolEffects of Trace Amine-associated Receptor 1 Agonists on the Expression, Reconsolidation, and Extinction of Cocaine Reward MemoryThe trace amine associated receptor 1 agonist RO5263397 attenuates the induction of cocaine behavioral sensitization in rats
P2860
Q21090974-D89502DA-753E-45A2-99E9-6D81EE8FF82FQ21129325-3F3A4B9A-F820-4B02-B086-8221CBE2800BQ21129458-669014D6-B879-446A-BF97-9E4DD372FFD7Q22252340-F1BD81AE-65AA-4870-813F-94A5341FF1E7Q26752602-74676037-450F-4226-96A0-0013CE15D461Q27310661-765AE7AA-D55B-4CCC-8F71-E7F169D34712Q28067851-A22E0686-EACC-4458-8FB7-905D4095B289Q28080716-7ED8C913-81EC-4B5A-AD4E-E6DA3C2CA189Q28239596-3CF9F83D-0143-4619-BC95-D465482F2607Q28242470-37ED93C6-6643-4050-94AD-0E6EADDD1780Q28255865-E5051C18-35E9-4D40-9F89-76E7FA8CAC2EQ28256783-8EE88C9E-A5AF-4AA7-8F3A-8981C599FA2CQ28270706-AA5957C2-0865-4911-B6AB-AB39C35A33F4Q28273207-558E01C4-B984-4A73-95A0-18FC48C9BD79Q28392199-B93BF601-8ADD-4E27-A18F-C9519AF247BDQ33742405-07B938AA-6F08-40B4-B211-BCA8224B08F6Q34068913-ED7802FD-FE38-4C25-81D5-2B495F2C2FC5Q34068926-EEB71A8D-923F-4A9E-9AD5-7145802D5110Q34337752-BC4936CE-0155-4BFA-8588-7B929F0FDC10Q34466872-4ACA0227-C0BC-469F-B98E-C864BD1B75EFQ34512348-85968C04-0877-49E4-9E98-AEF2BD1BEDAAQ34518566-1493EFEC-88D7-4496-8A04-6330AEB16FC1Q34520422-491375E4-E66A-4143-AA68-3ABCB1C789C5Q34550030-26CD7FAA-8927-4FD5-A46C-0FE5FB973610Q35007339-8AFAF278-D36B-483A-9A21-239CA9DFFB4CQ35179017-4F3F83E5-4DDB-4475-AD11-25BD484D128EQ35188101-380CF7AD-8F5B-419A-B9C2-DB2E4B821D5AQ35783781-CE1C6A4A-53CD-48DF-9855-BA866E448586Q35828177-F46ECECD-30AF-410E-B524-3569A1E694FBQ36106468-7F5016B9-E144-4063-AB4E-5915491EA0DAQ36164350-9B76F08C-0FD0-4265-A9DC-272911FC4437Q36184899-9610A08D-80CF-4219-850D-2A4B58AE8EC4Q36323501-9166C666-F485-436B-82B1-0A38C25AA454Q36323586-4D6CC632-C9CB-4C4E-B4A8-4718F968E8CBQ36610342-3F50A048-24A5-48A0-B810-8DA08CE8999EQ36746446-687554DC-2C54-46DE-8BCD-5EDB2253C35BQ36790759-8A59157D-7E94-425C-B88B-E5BA47C252D6Q36929548-93FDBEAE-0F8D-4D26-9835-C2A9C77C9E55Q37137786-88F7E14B-1629-4232-9106-F63E72DB51AAQ37710451-D61CF0DE-98F2-4994-BA7C-7083A3FFAD92
P2860
TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
TAAR1 activation modulates mon ...... and hypoglutamatergic activity
@ast
TAAR1 activation modulates mon ...... and hypoglutamatergic activity
@en
TAAR1 activation modulates mon ...... and hypoglutamatergic activity
@nl
type
label
TAAR1 activation modulates mon ...... and hypoglutamatergic activity
@ast
TAAR1 activation modulates mon ...... and hypoglutamatergic activity
@en
TAAR1 activation modulates mon ...... and hypoglutamatergic activity
@nl
prefLabel
TAAR1 activation modulates mon ...... and hypoglutamatergic activity
@ast
TAAR1 activation modulates mon ...... and hypoglutamatergic activity
@en
TAAR1 activation modulates mon ...... and hypoglutamatergic activity
@nl
P2093
P2860
P3181
P356
P1476
TAAR1 activation modulates mon ...... and hypoglutamatergic activity
@en
P2093
Amyaouch Bradaia
Bernhard Bettler
Bruno Pouzet
Claas A Meyer
Florent G Revel
Gerhard Trube
Jean-Luc Moreau
Joseph G Wettstein
Katrin Groebke Zbinden
Laurence Ozmen
P2860
P304
P3181
P356
10.1073/PNAS.1103029108
P407
P577
2011-04-27T00:00:00Z